Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Hersch

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Nature Methods|October 22, 2008
Linking SNPs to CAG repeat length in Huntington's disease patientsWanzhao Liu, Lori A Kennington, H Diana Rosas, et al.
Journal of Huntington'S Disease|December 17, 2016
LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's DiseaseVanita Chopra, Luisa Quinti, Prarthana Khanna, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 16, 2026
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic ModelPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLarisa Reyderman, Natasha Penner, Pratik Bhagunde, et al.
Annals of Neurology|January 6, 2025
Lecanemab-Associated Amyloid-β Protofibril in Cerebrospinal Fluid Correlates with Biomarkers of Neurodegeneration in Alzheimer's DiseaseMoeko Noguchi-Shinohara, Kazuyoshi Shuta, Hidetomo Murakami, et al.
Analytical Biochemistry|January 16, 2010
Identification of phenylbutyrate-generated metabolites in Huntington disease patients using parallel liquid chromatography/electrochemical array/mass spectrometry and off-line tandem mass spectrometryErika N Ebbel, Nancy Leymarie, Susan Schiavo, et al.
Scientific Reports|May 2, 2025
Ministring DNA (msDNA): a novel linear covalently-closed DNA with enhanced stability for gene and cell therapy applicationsWai Kuen Hung, Siddarth Chandrasekaran, Olga Zaslaver, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentNatasha Penner, Sumit Rawal, Jagadeesh Aluri, et al.
Analytical Biochemistry|December 8, 2010
Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell countAndreas Weiss, Stephan Grueninger, Dorothée Abramowski, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatmentPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Nature Methods|October 22, 2008
Linking SNPs to CAG repeat length in Huntington's disease patientsWanzhao Liu, Lori A Kennington, H Diana Rosas, et al.
Journal of Huntington'S Disease|December 17, 2016
LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's DiseaseVanita Chopra, Luisa Quinti, Prarthana Khanna, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 16, 2026
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic ModelPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLarisa Reyderman, Natasha Penner, Pratik Bhagunde, et al.
Annals of Neurology|January 6, 2025
Lecanemab-Associated Amyloid-β Protofibril in Cerebrospinal Fluid Correlates with Biomarkers of Neurodegeneration in Alzheimer's DiseaseMoeko Noguchi-Shinohara, Kazuyoshi Shuta, Hidetomo Murakami, et al.
Analytical Biochemistry|January 16, 2010
Identification of phenylbutyrate-generated metabolites in Huntington disease patients using parallel liquid chromatography/electrochemical array/mass spectrometry and off-line tandem mass spectrometryErika N Ebbel, Nancy Leymarie, Susan Schiavo, et al.
Scientific Reports|May 2, 2025
Ministring DNA (msDNA): a novel linear covalently-closed DNA with enhanced stability for gene and cell therapy applicationsWai Kuen Hung, Siddarth Chandrasekaran, Olga Zaslaver, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentNatasha Penner, Sumit Rawal, Jagadeesh Aluri, et al.
Analytical Biochemistry|December 8, 2010
Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell countAndreas Weiss, Stephan Grueninger, Dorothée Abramowski, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatmentPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Pageof 5